Janne M. Papma

Janne M. Papma

Auto-generated profile, based on publicly available information

Janne M. Papma

Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Neurology
Verified
Journal Article
Open access
PDF file
WEWillem S. Eikelboom
Willem S. Eikelboom
EBEsther van Den Berg
Esther van Den Berg
ESEllen H. Singleton
Ellen H. Singleton
SBSara J. Baart
Sara J. Baart
MCMichiel Coesmans
Michiel Coesmans
JPJanne M. Papma
Janne M. Papma
Objective: To investigate the prevalence and trajectories of neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of amyloid-β positive individuals across the Alzheimer’s disease (AD) clinical spectrum. Methods: In this single-center observational study, we included all individuals who visited the Alzheimer Center Amsterdam and had 1) a clinical diagnosis of subjective cognitive decline (SCD), mild cognitive impairment (MCI), or probable AD dementia, and 2) were amyloid-β positive (A+). We measured NPS with the Neuropsychiatric Inventory (NPI), examining total scores and the presence of specific NPI domains. Cognition was assessed across five cognitive domains and with the MMSE. We examined trajectories including model based trends for NPS and cognitive functioning over time. We used linear mixed models to relate baseline NPI scores to cognitive functioning at baseline (whole-sample) and longitudinal time-points (subsample n=520, Mean=1.8 [SD=0.7] years follow-up). Results: We included 1,524 amyloid-β positive individuals from the Amsterdam Dementia Cohort with A+ SCD (n=113), A+ MCI (n=321), or A+ AD dementia (n=1,090). NPS were prevalent across all clinical AD stages (≥1 NPS 81.4% in SCD, 81.2% in MCI, 88.7% in dementia; ≥1 clinically relevant NPS 54.0% in SCD, 50.5% in MCI, 66.0% in dementia). Cognitive functioning showed an uniform gradual decline; while in contrast, large intra-individual heterogeneity of NPS was observed over time across all AD groups. At baseline, we found associations between NPS and cognition in dementia that were most pronounced for NPI total scores and MMSE (range β=0.18 to 0.11, FDR-adjusted p0.05). There were no associations between baseline NPS and cognitive functioning over time in any clinical stage (range β=-0.13 to 0.44, all FDR-adjusted p>0.05). Conclusion: NPS and cognitive symptoms are both prevalent across the AD continuum, but show a different evolution during the course of the disease.

19 September 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
JPJanne M. Papma
Janne M. Papma
LJLize C. Jiskoot
Lize C. Jiskoot
JPJessica L. Panman
Jessica L. Panman
EDElise G. Dopper
Elise G. Dopper
THTom Den Heijer
Tom Den Heijer
JSJohn C. van Swieten
John C. van Swieten
Objective: To investigate cognitive function, gray matter volume, and white matter integrity in the presymptomatic stage of chromosome 9 open reading frame 72 repeat expansion (C9orf72RE). Methods: Presymptomatic C9orf72RE carriers (n = 18) and first-degree family members without a pathogenic expansion (healthy controls [HC], n = 15) underwent a standardized protocol of neuropsychological tests, T1-weighted MRI, and diffusion tensor imaging within our cohort study of autosomal dominant frontotemporal dementia (FTD). We investigated group differences in cognitive function, gray matter volume through voxel-based morphometry, and white matter integrity by means of tract-based spatial statistics. We correlated cognitive change with underlying gray or white matter. Results: Our data demonstrate lower scores on letter fluency, Stroop card I, and Stroop card III, accompanied by white matter integrity loss in tracts connecting the frontal lobe, the thalamic radiation, and tracts associated with motor functioning in presymptomatic C9orf72RE compared with HC. In a subgroup of C9orf72RE carriers above 40 years of age, we found gray matter volume loss in the thalamus, cerebellum, and parietal and temporal cortex. We found no significant relationship between subtle cognitive decline and underlying gray or white matter. Conclusions: This study demonstrates that a decline in cognitive functioning, white matter integrity, and gray matter volumes are present in presymptomatic C9orf72RE carriers. These findings suggest that neuropsychological assessment, T1-weighted MRI, and diffusion tensor imaging might be useful to identify early biomarkers in the presymptomatic stage of FTD or amyotrophic lateral sclerosis.

12 September 2019 in Journal of the International Neuropsychological Society
Verified
Journal Article
Open access
PDF file
SFSanne Franzen
Sanne Franzen
EBEsther van Den Berg
Esther van Den Berg
MGMiriam Goudsmit
Miriam Goudsmit
CJCaroline K. Jurgens
Caroline K. Jurgens
LWLotte van de Wiel
Lotte van de Wiel
JPJanne M. Papma
Janne M. Papma
Objective: Neuropsychological tests are important instruments to determine a cognitive profile, giving insight into the etiology of dementia; however, these tests cannot readily be used in culturally diverse, low-educated populations, due to their dependence upon (Western) culture, education, and literacy. In this review we aim to give an overview of studies investigating domain-specific cognitive tests used to assess dementia in non-Western, low-educated populations. The second aim was to examine the quality of these studies and of the adaptations for culturally, linguistically, and educationally diverse populations.Method: A systematic review was performed using six databases, without restrictions on the year or language of publication.Results: Forty-four studies were included, stemming mainly from Brazil, Hong Kong, Korea, and considering Hispanics/Latinos residing in the USA. Most studies focused on Alzheimer’s disease (n= 17) or unspecified dementia (n= 16). Memory (n= 18) was studied most often, using 14 different tests. The traditional Western tests in the domains of attention (n= 8) and construction (n= 15), were unsuitable for low-educated patients. There was little variety in instruments measuring executive functioning (two tests,n= 13), and language (n= 12, of which 10 were naming tests). Many studies did not report a thorough adaptation procedure (n= 39) or blinding procedures (n= 29).Conclusions: Various formats of memory tests seem suitable for low-educated, non-Western populations. Promising tasks in other cognitive domains are the Stick Design Test, Five Digit Test, and verbal fluency test. Further research is needed regarding cross-cultural instruments measuring executive functioning and language in low-educated people.

1 April 2019 in Neurobiology of Aging
Verified
Journal Article
Open access
JPJessica L. Panman
Jessica L. Panman
LJLize C. Jiskoot
Lize C. Jiskoot
MBMark J.R.J. Bouts
Mark J.R.J. Bouts
LMLieke H.H. Meeter
Lieke H.H. Meeter
EEEmma L. van der Ende
Emma L. van der Ende
JPJanne M. Papma
Janne M. Papma
In genetic frontotemporal dementia, cross-sectional studies have identified profiles of presymptomatic neuroanatomical loss for C9orf72 repeat expansion, MAPT, and GRN mutations. In this study, we characterize longitudinal gray matter (GM) and white matter (WM) brain changes in presymptomatic frontotemporal dementia. We included healthy carriers of C9orf72 repeat expansion (n = 12), MAPT (n = 15), GRN (n = 33) mutations, and related noncarriers (n = 53), that underwent magnetic resonance imaging at baseline and 2-year follow-up. We analyzed cross-sectional baseline, follow-up, and longitudinal GM and WM changes using voxel-based morphometry and cortical thickness analysis in SPM and tract-based spatial statistics in FSL. Compared with noncarriers, C9orf72 repeat expansion carriers showed lower GM volume in the cerebellum and insula, and WM differences in the anterior thalamic radiation, at baseline and follow-up. MAPT mutation carriers showed emerging GM temporal lobe changes and longitudinal WM degeneration of the uncinate fasciculus. GRN mutation carriers did not show presymptomatic neurodegeneration. This study shows distinct presymptomatic cross-sectional and longitudinal patterns of GM and WM changes across C9orf72 repeat expansion, MAPT, and GRN mutation carriers compared with noncarriers.

23 September 2013 in Human Brain Mapping
Verified
Journal Article
Closed access
PDF file
JPJanne M. Papma
Janne M. Papma
MGMarius de Groot
Marius de Groot
IKInge de Koning
Inge de Koning
FMFrancesco U. Mattace‐Raso
Francesco U. Mattace‐Raso
ALAad van der Lugt
Aad van der Lugt
MSMarion Smits
Marion Smits

7 April 2018 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
LJLize C. Jiskoot
Lize C. Jiskoot
JPJessica L. Panman
Jessica L. Panman
LALauren van Asseldonk
Lauren van Asseldonk
SFSanne Franzen
Sanne Franzen
LMLieke H. H. Meeter
Lieke H. H. Meeter
JPJanne M. Papma
Janne M. Papma
Introduction We performed 4-year follow-up neuropsychological assessment to investigate cognitive decline and the prognostic abilities from presymptomatic to symptomatic familial frontotemporal dementia (FTD). Methods Presymptomatic MAPT (n = 15) and GRN mutation carriers (n = 31), and healthy controls (n = 39) underwent neuropsychological assessment every 2 years. Eight mutation carriers (5 MAPT, 3 GRN) became symptomatic. We investigated cognitive decline with multilevel regression modeling; the prognostic performance was assessed with ROC analyses and stepwise logistic regression. Results MAPT converters declined on language, attention, executive function, social cognition, and memory, and GRN converters declined on attention and executive function (p < 0.05). Cognitive decline in ScreeLing phonology (p = 0.046) and letter fluency (p = 0.046) were predictive for conversion to non-fluent variant PPA, and decline on categorical fluency (p = 0.025) for an underlying MAPT mutation. Discussion Using longitudinal neuropsychological assessment, we detected a mutation-specific pattern of cognitive decline, potentially suggesting prognostic value of neuropsychological trajectories in conversion to symptomatic FTD.